Literature DB >> 9596776

Entamoeba histolytica induces host cell death in amebic liver abscess by a non-Fas-dependent, non-tumor necrosis factor alpha-dependent pathway of apoptosis.

K B Seydel1, S L Stanley.   

Abstract

Amebic liver abscess is characterized by extensive areas of dead hepatocytes that form cavities surrounded by a thin rim of inflammatory cells and few Entamoeba histolytica trophozoites. E. histolytica produces pore-forming proteins and proteinases, but how trophozoites actually kill host cells has been unclear. Here, we report that E. histolytica induces apoptosis in both inflammatory cells and hepatocytes in a severe combined immunodeficient (SCID) mouse model of amebic liver abscess. By studying infection in C57/BL6.lpr and C57/BL6.gld mice, we found that E. histolytica-induced apoptosis does not require the Fas/Fas ligand pathway of apoptosis, and by using mice with a targeted deletion of the tumor necrosis factor receptor I gene, we have shown that E. histolytica-induced apoptosis is not mediated by tumor necrosis factor alpha. Our data indicate that apoptosis plays a prominent role in the host cell death seen in amebic liver abscess in a mouse model of disease and suggest that E. histolytica induces cell death without using two common pathways for apoptosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9596776      PMCID: PMC108298          DOI: 10.1128/IAI.66.6.2980-2983.1998

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  Ancient weapons: NK-lysin, is a mammalian homolog to pore-forming peptides of a protozoan parasite.

Authors:  M Leippe
Journal:  Cell       Date:  1995-10-06       Impact factor: 41.582

2.  Neutrophils play a critical role in early resistance to amebic liver abscesses in severe combined immunodeficient mice.

Authors:  K B Seydel; T Zhang; S L Stanley
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

3.  Necrosis versus apoptosis as the mechanism of target cell death induced by Entamoeba histolytica.

Authors:  O Berninghausen; M Leippe
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

4.  The type B receptor for tumor necrosis factor-alpha mediates DNA fragmentation in HL-60 and U937 cells and differentiation in HL-60 cells.

Authors:  M S Greenblatt; L Elias
Journal:  Blood       Date:  1992-09-01       Impact factor: 22.113

5.  Preferential distribution of apoptotic bodies in acinar zone 3 of normal human and rat liver.

Authors:  A Benedetti; A M Jézéquel; F Orlandi
Journal:  J Hepatol       Date:  1988-12       Impact factor: 25.083

6.  Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.

Authors:  T Takahashi; M Tanaka; C I Brannan; N A Jenkins; N G Copeland; T Suda; S Nagata
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

7.  Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models.

Authors:  M Leist; F Gantner; I Bohlinger; G Tiegs; P G Germann; A Wendel
Journal:  Am J Pathol       Date:  1995-05       Impact factor: 4.307

Review 8.  The Fas death factor.

Authors:  S Nagata; P Golstein
Journal:  Science       Date:  1995-03-10       Impact factor: 47.728

9.  Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.

Authors:  P R Galle; W J Hofmann; H Walczak; H Schaller; G Otto; W Stremmel; P H Krammer; L Runkel
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

10.  A severe combined immunodeficient (SCID) mouse model for infection with Entamoeba histolytica.

Authors:  P R Cieslak; H W Virgin; S L Stanley
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

View more
  31 in total

Review 1.  Apoptosis and the balance of homeostatic and pathologic responses to protozoan infection.

Authors:  L Cristina Gavrilescu; Eric Y Denkers
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

Review 2.  Role of intestinal mucins in innate host defense mechanisms against pathogens.

Authors:  Poonam Dharmani; Vikas Srivastava; Vanessa Kissoon-Singh; Kris Chadee
Journal:  J Innate Immun       Date:  2008-10-08       Impact factor: 7.349

Review 3.  Tissue destruction and invasion by Entamoeba histolytica.

Authors:  Katherine S Ralston; William A Petri
Journal:  Trends Parasitol       Date:  2011-03-26

4.  Direct and high-throughput assays for human cell killing through trogocytosis by Entamoeba histolytica.

Authors:  Akhila Bettadapur; Katherine S Ralston
Journal:  Mol Biochem Parasitol       Date:  2020-07-17       Impact factor: 1.759

5.  Entamoeba histolytica and Entamoeba dispar utilize externalized phosphatidylserine for recognition and phagocytosis of erythrocytes.

Authors:  Douglas R Boettner; Christopher D Huston; James A Sullivan; William A Petri
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

6.  Identification of an Entamoeba histolytica serine-, threonine-, and isoleucine-rich protein with roles in adhesion and cytotoxicity.

Authors:  Ryan C MacFarlane; Upinder Singh
Journal:  Eukaryot Cell       Date:  2007-09-07

Review 7.  New insights into host-pathogen interactions during Entamoeba histolytica liver infection.

Authors:  D M Faust; J Marquay Markiewicz; J Santi-Rocca; N Guillen
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2011-03

8.  Apoptosis induced by parasitic diseases.

Authors:  Anne-Lise Bienvenu; Elena Gonzalez-Rey; Stephane Picot
Journal:  Parasit Vectors       Date:  2010-11-17       Impact factor: 3.876

9.  Role of GABA and serotonin coupled chitosan nanoparticles in enhanced hepatocyte proliferation.

Authors:  J Shilpa; B T Roshni; R Chinthu; C S Paulose
Journal:  J Mater Sci Mater Med       Date:  2012-09-08       Impact factor: 3.896

10.  Epithelial cell apoptosis facilitates Entamoeba histolytica infection in the gut.

Authors:  Stephen M Becker; Kyou-Nam Cho; Xiaoti Guo; Kirsten Fendig; Mohammed N Oosman; Robert Whitehead; Steven M Cohn; Eric R Houpt
Journal:  Am J Pathol       Date:  2010-01-21       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.